A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05354089 |
|
Recruitment Status :
Enrolling by invitation
First Posted : April 29, 2022
Last Update Posted : December 21, 2022
|
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Information provided by (Responsible Party):
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Actual Primary Completion Date : | July 9, 2022 |
| Estimated Study Completion Date : | October 1, 2023 |